These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3377325)

  • 1. Mechanism and management of persistent withdrawal occlusion.
    Tschirhart JM; Rao MK
    Am Surg; 1988 Jun; 54(6):326-8. PubMed ID: 3377325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy extravasation: a consequence of fibrin sheath formation around venous access devices.
    Mayo DJ; Pearson DC
    Oncol Nurs Forum; 1995 May; 22(4):675-80. PubMed ID: 7675669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
    Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.
    Bagnall HA; Gomperts E; Atkinson JB
    Pediatrics; 1989 Jun; 83(6):963-6. PubMed ID: 2657625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin sheath formation and chemotherapy extravasation: a case report.
    Mayo DJ
    Support Care Cancer; 1998 Jan; 6(1):51-6. PubMed ID: 9458537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase therapy in neonates with catheter related central venous thrombosis.
    Wever ML; Liem KD; Geven WB; Tanke RB
    Thromb Haemost; 1995 Feb; 73(2):180-5. PubMed ID: 7792727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aetiology and management of persistent withdrawal occlusion in venous ports in oncology patients.
    Maňásek V; Zapletalová J; Olosová L; Filáková I; Kociánová I; Drdová K; Škarda J; Chovanec V; Vrána D
    Sci Prog; 2024; 107(3):368504241260374. PubMed ID: 39096050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous port salvage utilizing low dose tPA.
    Whigham CJ; Lindsey JI; Goodman CJ; Fisher RG
    Cardiovasc Intervent Radiol; 2002; 25(6):513-6. PubMed ID: 12391517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ultrasound-based technique in the management of totally implantable venous access devices with persistent withdrawal occlusion.
    D'Arrigo S; Annetta MG; Pittiruti M
    J Vasc Access; 2023 Jan; 24(1):140-144. PubMed ID: 34096379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing peripherally inserted central catheter-related venous thrombosis: How I do it.
    Chaitowitz I; Heng R; Bell K
    Australas Radiol; 2006 Apr; 50(2):132-5. PubMed ID: 16635031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin sheaths in vascular access devices.
    Gabriel J
    Nurs Times; 1997 Mar 5-11; 93(10):56-7. PubMed ID: 9121892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful treatment of a right atrial thrombus secondary to central venous catheterization].
    Adamovich K; Tárnok A; Szauer E
    Orv Hetil; 1999 Jun; 140(26):1467-70. PubMed ID: 10442003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study.
    Dillon PW; Jones GR; Bagnall-Reeb HA; Buckley JD; Wiener ES; Haase GM;
    J Clin Oncol; 2004 Jul; 22(13):2718-23. PubMed ID: 15226339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Venous thrombosis in relation to central venous catheters: pathogenesis, diagnosis, therapy, possibilities of prophylaxis].
    Hájek R; Matýsková M
    Vnitr Lek; 1995 Jun; 41(6):415-20. PubMed ID: 7676664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying complications of central venous catheters: infection, thrombosis, occlusion.
    Prescrire Int; 2009 Aug; 18(102):173-4. PubMed ID: 19746562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic therapy for management of complicated catheter-related Candida albicans thrombophlebitis.
    Block AA; Thursky KA; Worth LJ; Slavin MA
    Intern Med J; 2009 Jan; 39(1):61-3. PubMed ID: 19290985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clot lysis for thrombosed central venous catheters in pediatric patients.
    Kellam B; Fraze D; Kanarek KS
    J Perinatol; 1987; 7(3):242-4. PubMed ID: 3504465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial.
    Haire WD; Atkinson JB; Stephens LC; Kotulak GD
    Thromb Haemost; 1994 Oct; 72(4):543-7. PubMed ID: 7878629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of catheter loops in central venous port systems.
    Behrendt FF; Wingen M; Katoh M; Guenther RW; Buecker A
    Invest Radiol; 2006 Nov; 41(11):777-80. PubMed ID: 17035867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.